CAREDX INC
NASDAQ: CDNA (CareDx, Inc.)
Kemas kini terakhir: 20 jam lalu22.33
0.81 (3.76%)
| Penutupan Terdahulu | 21.52 |
| Buka | 21.67 |
| Jumlah Dagangan | 334,117 |
| Purata Dagangan (3B) | 820,419 |
| Modal Pasaran | 1,197,644,928 |
| Harga / Jualan (P/S) | 4.21 |
| Harga / Buku (P/B) | 4.91 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | -45.90% |
| Margin Operasi (TTM) | -12.66% |
| EPS Cair (TTM) | -2.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 23.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.97% |
| Nisbah Semasa (MRQ) | 4.10 |
| Aliran Tunai Operasi (OCF TTM) | 7.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 19.38 M |
| Pulangan Atas Aset (ROA TTM) | -7.50% |
| Pulangan Atas Ekuiti (ROE TTM) | -43.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | CareDx, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.75 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.45% |
| % Dimiliki oleh Institusi | 96.05% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bellevue Group Ag | 30 Sep 2024 | 3,145,456 |
| Gagnon Securities Llc | 30 Sep 2024 | 1,437,722 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 35.00 (BTIG, 56.74%) | Beli |
| 35.00 (Goldman Sachs, 56.74%) | Beli | |
| Median | 35.00 (56.74%) | |
| Purata | 35.00 (56.74%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 24.54 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 05 Nov 2024 | 35.00 (56.74%) | Beli | 22.90 |
| Goldman Sachs | 16 Oct 2024 | 35.00 (56.74%) | Beli | 26.18 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |